Approval · Notice of Compliance 26633 · 2021
INREBIC: Notice of Compliance 26633
Issued September 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26633
- Date
- September 10, 2021
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph; and to migrate the Product Monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INREBIC | Not yet assigned | — |
Medicinal ingredients
- FEDRATINIB HYDROCHLORIDE 100 MG per CAP